Peptide COAs
Nad+
43 public audits matching your filters. Scores are PeptIQ’s legitimacy model; missing panels lower thoroughness but aren’t automatically “bad” — open a report to see pass, fail, reported, and missing panels clearly.
Public certificates
Approved community and directory-linked COAs only.
- NAD+ + Nicotinamide Adenine Dinucleotide
American Peptide Research · Jul 29, 2026 · 2/7 panels · 99.45% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - NAD+ + Nicotinamide Adenine Dinucleotide
American Peptide Research · Jul 29, 2026 · 2/7 panels · 99.52% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - NAD+ + Nicotinamide Adenine Dinucleotide
American Peptide Research · Jul 29, 2026 · 2/7 panels · 99.52% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - NAD+ + Nicotinamide Adenine Dinucleotide
American Peptide Research · Jul 29, 2026 · 2/7 panels · 99.45% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - NAD+ + Nicotinamide Adenine Dinucleotide
Peptide Partners · Jul 29, 2026 · 2/7 panels · 99.56% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - Buffered NAD+
Peptide Partners · Jul 28, 2026 · 1/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - Buffered NAD+
Peptide Partners · Jul 28, 2026 · 1/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - Buffered NAD+ + NAD+
Peptide Partners · Jul 28, 2026 · 4/7 panels · 99.956% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - NAD 500mg + NAD+
Crush Research · Jul 28, 2026 · 5/7 panels · 99% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - NAD+
Crush Research · Jul 28, 2026 · 5/7 panels · 99.44% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - NAD+
Crush Research · Jul 28, 2026 · 5/7 panels · 99.22% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - NAD+
Crush Research · Jul 28, 2026 · 5/7 panels · 99.27% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - NAD+
Crush Research · Jul 28, 2026 · 5/7 panels · 99.38% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - NAD (+) + NAD+
Lumira · Jul 29, 2026 · 2/7 panels · 99.7% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - NAD+ + Nicotinamide adenine dinucleotide
Peptide Partners · Jul 28, 2026 · 2/7 panels · 99.76% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - NAD+ + NAD+ 1000mg
Blank Peptides · Jul 28, 2026 · 4/7 panels · 99.24% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - NAD+ + Nicotinamide Adenine Dinucleotide
Blank Peptides · Jul 28, 2026 · 2/7 panels · 99.94% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - NAD+ + NAD+ 500mg
Blank Peptides · Jul 28, 2026 · 2/7 panels · 99.85% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - NAD+ + Nicotinamide Adenine Dinucleotide
American Peptide Research · Jul 29, 2026 · 2/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - NAD+ + Nicotinamide Adenine Dinucleotide
American Peptide Research · Jul 29, 2026 · 1/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - NAD+
Peptide Partners · Jul 29, 2026 · 1/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - NAD+ + Nicotinamide Adenine Dinucleotide
Peptide Partners · Jul 28, 2026 · 1/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - NAD+ + NAD+ 500mg
Brand not listed · Jul 28, 2026 · 2/7 panels · 99.86% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - NAD+ + NAD+ 500mg BUFFERED
Blank Peptides · Jul 28, 2026 · 4/7 panels · 99.91% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - NAD+ + NAD+ 500mg (Buffered)
Blank Peptides · Jul 28, 2026 · 3/7 panels · 99.52% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - NAD+ + Nicotinamide Adenine Dinucleotide
Blank Peptides · Jul 28, 2026 · 4/7 panels · 99.97% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - NAD+ + Nicotinamide Adenine Dinucleotide
Blank Peptides · Jul 28, 2026 · 3/7 panels · 99.35% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - NAD+ + Nicotinamide Adenine Dinucleotide
Blank Peptides · Jul 28, 2026 · 2/7 panels · 99.94% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - NAD+
Blank Peptides · Jul 28, 2026 · 2/7 panels · 99.895% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns68 - NAD+
Peptide Partners · Jul 29, 2026 · 1/7 panels
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation62 - NAD+ + Nicotinamide Adenine Dinucleotide
American Peptide Research · Jul 29, 2026 · 1/7 panels
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation45 - NAD+ + Nicotinamide Adenine Dinucleotide
American Peptide Research · Jul 29, 2026 · 1/7 panels
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation45 - NAD+ + NAD+ Bio Fermented
Paramount Peptides · Jul 29, 2026 · 0/7 panels
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation45 - NAD+
Paramount Peptides · Jul 29, 2026 · 1/7 panels
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation45 - NAD+
Peptide Partners · Jul 29, 2026 · 1/7 panels
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation45 - NAD+
Peptide Partners · Jul 28, 2026 · 1/7 panels
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation45 - NAD+
Blank Peptides · Jul 28, 2026 · 1/7 panels
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation45 - NAD+ + Nicotinamide Adenine Dinucleotide
Brand not listed · Jul 28, 2026 · 1/7 panels
Missing panels or key metadata — not enough evidence to treat this as a full certificate.
Incomplete documentation45
Community-sourced
Help build the COA record
PeptIQ’s market snapshot comes from moderator-approved certificates and curated peptide brands and testing laboratories — not invented stats. Contribute a COA or claim your listing.
Community submissions are reviewed before they appear on public market pages. Private COA scans stay private until you share them.
Brand owners: claim or list your peptide brand, upload COAs tied to it in the app, then track trust scores on your public brand page and the COA market.
Upload a COA
Scan a certificate of analysis in the app. Public shares go through review before the market.
List / claim a peptide brand
Apply to list or claim your vendor profile. Listings stay unpublished until PeptIQ approves them.
Claim / list a testing laboratory
Third-party peptide testing labs (HPLC, endotoxin, etc.) can claim or request a directory presence.
See brand trust & reputation
Browse vendor trust scores and legitimacy from moderator-approved public COAs on the market.
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.